Coverage for Oral Anti-Cancer Drugs


SB 152 NC Cancer Treatment Fairness

Primary Sponsors: Sen. Ralph Hise (R – Madison), Sen. Jerry Tillman (R – Moore), Sen. Andrew Brock (R – Davie)

If passed, this bill would require health benefit plans to provide coverage for prescribed, orally administered anticancer drugs. The bill states coverage for orally administered anticancer drugs would not be subject to prior authorization dollar limits, co-payments, coinsurance or deductible provisions or out of pocket costs. The bill also states  insurers cannot reclassify anticancer drugs in order to comply with this bill.


More Posts in 2017 Legislative Session


Share this Post


Leave a Reply

The NCMS moderates this blog, so expect a slight delay in posting. Please include your full name and affiliation. We insist on respectful dialogue and reserve the right not to post remarks incompatible with our guidelines.

Your email address will not be published. Required fields are marked *